Resatorvid

Phase 3Small molecule

Takeda

Resatorvid is one of 59 small molecule programs targeting Respiratory Failure. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Respiratory FailureActive, not recruiting

SepsisActive, not recruiting

Respiratory FailurePhase 3

Active, not recruiting

SepsisPhase 3

Active, not recruiting

Competition

Competitive Landscape

308 competitors in Sepsis

#DrugCompanyPhaseTrials

Resatorvid

Takeda

Phase 3

1 2

Corlanor

Amgen

Preclinical

2 3

Simdax

Orion Corporation, Orion Pharma

Preclinical

1 4

Zemplar

Primaxin

Brevibloc

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

3 7

Levophed

GGeneral Hospital of Ningxia Medical University

Preclinical

2 8

Epsom Salt

FFresenius Kabi Oncology Ltd.

Preclinical

1 9

Aquasol a

BBandim Health Project

Preclinical

1 10

Micardis

Boehringer Ingelheim

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Sepsis1 trial

Efficacy & Safety of Resatorvid in Adults With Severe Sepsis

Completed· Takeda logo

Takeda·Phase 3·NCT00143611·277 enrolled

Respiratory Failure1 trial

Efficacy and Safety of Resatorvid in Patients With Sepsis-induced Cardiovascular and Respiratory Failure

Terminated· Takeda logo

Takeda·Phase 3·NCT00633477·18 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Resatorvid. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Resatorvid compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Resatorvid. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Takeda company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Takeda

Resatorvid

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Sepsis1 trial

Respiratory Failure1 trial

References

Drug Info

Quick Facts

Related News